{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:11:52Z","timestamp":1775909512922,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ahj.2004.03.066","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:02:41Z","timestamp":1103155361000},"page":"990-997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trials"],"prefix":"10.1016","volume":"148","author":[{"given":"Mark D.","family":"Schleinitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingram","family":"Olkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.03.066_BIB1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.CIR.98.2.104","article-title":"Intracoronary stenting and risk for major adverse cardiac events during the first month","volume":"98","author":"Schuhlen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(02)02374-4","article-title":"Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry","volume":"40","author":"Orford","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199101033240103","article-title":"Angiographic follow-up after placement of a self-expanding coronary-artery stent","volume":"324","author":"Serruys","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0735-1097(95)00466-1","article-title":"Subacute stent thrombosis: evolving issues and current concepts","volume":"27","author":"Mak","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB8","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Schomig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB10","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.98.20.2126","article-title":"Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)","volume":"98","author":"Urban","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB11","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.98.16.1597","article-title":"Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study","volume":"98","author":"Bertrand","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000331970005100403","article-title":"Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting","volume":"51","author":"Foussas","year":"2000","journal-title":"Angiology"},{"key":"10.1016\/j.ahj.2004.03.066_BIB13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Gent","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.03.066_BIB14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-128-7-199804010-00004","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine","volume":"128","author":"Bennett","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB15","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1023\/A:1026658320577","article-title":"Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature","volume":"43","author":"Iqbal","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ahj.2004.03.066_BIB16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.CIR.101.6.590","article-title":"A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents","volume":"101","author":"Muller","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc3001.093435","article-title":"Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population","volume":"104","author":"Taniuchi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB19","first-page":"1701","article-title":"Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up","volume":"84","author":"Piamsomboon","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ahj.2004.03.066_BIB20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0149-2918(97)80058-6","article-title":"A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation","volume":"19","author":"Kunishima","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.ahj.2004.03.066_BIB21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9149(99)00368-9","article-title":"Comparison of cilostazol versus ticlopidine therapy after stent implantation","volume":"84","author":"Park","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0002-9149(99)00579-2","article-title":"Usefulness of cilostazol versus ticlopidine in coronary artery stenting","volume":"84","author":"Yoon","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0002-9149(99)00501-9","article-title":"Impact of cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction","volume":"84","author":"Ochiai","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9149(98)00323-3","article-title":"Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis","volume":"82","author":"Sekiya","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mhj.2001.111548","article-title":"Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation","volume":"141","author":"Kozuma","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2004.03.066_BIB26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1067\/mjh.2002.122874","article-title":"Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restensosis","volume":"144","author":"Kamishirado","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2004.03.066_BIB27","series-title":"Meta-analysis in medicine and health policy","article-title":"Meta-analysis for 2\u00d72 tables with multiple treatment groups","author":"Gleser","year":"2000"},{"key":"10.1016\/j.ahj.2004.03.066_BIB28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.CIR.93.2.215","article-title":"A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation","volume":"93","author":"Hall","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB29","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0735-1097(99)00443-X","article-title":"Clopidogrel as adjunctive antiplatelet therapy during coronary stenting","volume":"34","author":"Mishkel","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0002-9149(00)01408-9","article-title":"Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting","volume":"87","author":"Dangas","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1067\/mhj.2000.108825","article-title":"Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents","volume":"140","author":"Calver","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2004.03.066_BIB32","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0735-1097(99)00442-8","article-title":"Clopidogrel versus ticlopidine after intracoronary stent placement","volume":"34","author":"Berger","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB33","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.CIR.99.18.2364","article-title":"Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation","volume":"99","author":"Moussa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB34","first-page":"436","article-title":"Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen","volume":"55","author":"Pache","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2004.03.066_BIB35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-5273(01)00388-6","article-title":"Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine","volume":"78","author":"Tanabe","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB36","first-page":"1041","article-title":"Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting","volume":"19","author":"L'Allier","year":"2003","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0735-1097(01)01713-2","article-title":"Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting","volume":"39","author":"Bhatt","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB39","first-page":"563","article-title":"Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo","volume":"37","author":"Ikeda","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ahj.2004.03.066_BIB40","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMoa021007","article-title":"A paclitaxel-eluting stent for the prevention of coronary restenosis","volume":"348","author":"Park","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.99.2.248","article-title":"Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement","volume":"99","author":"Berger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.03.066_BIB42","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/S0735-1097(01)01285-2","article-title":"Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen","volume":"37","author":"Schuhlen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB43","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2004.03.066_BIB44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9149(00)01001-8","article-title":"Effects of cilostazol on angiographic restenosis after coronary stent placement","volume":"86","author":"Park","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB45","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel","volume":"342","author":"Bennett","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB46","first-page":"1193","volume":"343","author":"Bennett","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB47","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE study research group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.03.066_BIB48","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00005344-199910000-00004","article-title":"Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells","volume":"34","author":"Cone","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB49","first-page":"140","article-title":"Rapid ventricular tachycardias associated with cilostazol use","volume":"29","author":"Gamssari","year":"2002","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.ahj.2004.03.066_BIB50","doi-asserted-by":"crossref","first-page":"28D","DOI":"10.1016\/S0002-9149(01)01719-2","article-title":"Analysis of the cilostazol safety database","volume":"87","author":"Pratt","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.03.066_BIB51","series-title":"Drug Topics Red Book","year":"2003"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304005101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304005101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:12:37Z","timestamp":1757567557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304005101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0002870304005101"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.03.066","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.03.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}